Factor IX ectopically expressed in platelets can be stored in α-granules and corrects the phenotype of hemophilia B mice

  1. Guowei Zhang1,
  2. Qizhen Shi1,
  3. Scot A Fahs2,
  4. Erin L Kuether3,
  5. Christopher E Walsh4, and
  6. Robert R Montgomery1,*
  1. 1 Dept. of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, United States;
  2. 2 Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, Wisconsin, United States;
  3. 3 Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States;
  4. 4 Mount Sinai School of Medicine, New York, NY, United States
  1. * Corresponding author; email: bob.montgomery{at}bcw.edu

Abstract

We developed 2bF9 transgenic mice in a hemophilia B mouse model with the expression of human factor IX (FIX) under control of the platelet-specific integrin αIIb promoter, to determine whether ectopically expressing FIX in megakaryocytes can enable the storage of FIX in platelet α-granules and corrects murine hemophilia B phenotype. FIX was detected in the platelets and plasma of 2bF9 transgenic mice by both antigen and activity assays. About 90% of total FIX in blood was stored in platelets, most of which is releasable upon activation of platelets. Immuno-staining demonstrated that FIX was expressed in platelets and megakaryocytes and stored in α-granules. All 2bF9 transgenic mice survived tail clipping, suggesting that platelet-derived FIX normalizes hemostasis in the hemophilia B mouse model. This protection can be transferred by bone marrow transplantation or platelet transfusion. However, unlike our experience with platelet FVIII, the efficacy of platelet-derived FIX was limited in the presence of anti-FIX inhibitory antibodies. These results demonstrate that releasable FIX can be expressed and stored in platelet α-granules, and that platelet-derived FIX can correct the bleeding phenotype in hemophilia B mice. Our studies suggest that targeting FIX expression to platelets could be a new gene therapy strategy for hemophilia B.

  • Submitted November 24, 2009.
  • Accepted April 24, 2010.

This Article

  1. Blood May 5, 2010 blood-2009-11-255612
  1. Supplemental Methods and Figures
  2. All Versions of this Article:
    1. blood-2009-11-255612v1
    2. 116/8/1235 most recent

Classifications

e-Letters